Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
Assessment of PD-1 and PD-L1 expression can be predictive of immunotherapy response in lung cancer. Here the authors assess the clinical toxicity, safety and quality of non-invasive imaging of PD-1 and PD-L1 expression in 13 patients with advanced lung cancer prior to treatment with immunotherapy an...
Full description
Bibliographic Details
Main Authors: |
A. N. Niemeijer,
D. Leung,
M. C. Huisman,
I. Bahce,
O. S. Hoekstra,
G. A. M. S. van Dongen,
R. Boellaard,
S. Du,
W. Hayes,
R. Smith,
A. D. Windhorst,
N. H. Hendrikse,
A. Poot,
D. J. Vugts,
E. Thunnissen,
P. Morin,
D. Lipovsek,
D. J. Donnelly,
S. J. Bonacorsi,
L. M. Velasquez,
T. D. de Gruijl,
E. F. Smit,
A. J. de Langen |
Format: | Article
|
Language: | English |
Published: |
Nature Portfolio
2018-11-01
|
Series: | Nature Communications
|
Online Access: | https://doi.org/10.1038/s41467-018-07131-y
|